853
Views
4
CrossRef citations to date
0
Altmetric
Review

Optimizing the timing of 4CMenB vaccination in adolescents and young adults based on immune persistence and booster response data

Pages 343-352 | Received 04 Dec 2018, Accepted 05 Feb 2019, Published online: 22 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Justine Alderfer, Raul E. Isturiz & Amit Srivastava. (2020) Lessons from mass vaccination response to meningococcal B outbreaks at US universities. Postgraduate Medicine 132:7, pages 614-623.
Read now
Federico Martinón-Torres, Terry Nolan, Daniela Toneatto & Angelika Banzhoff. (2019) Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults. Human Vaccines & Immunotherapeutics 15:12, pages 2940-2951.
Read now

Articles from other publishers (2)

David S. Stephens, Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2023. Plotkin's Vaccines. Plotkin's Vaccines 690 710.e7 .
Christine Robin, Rabah Redjoul, Aude Terrade, Ala-Eddine Deghmane, Ludovic Cabanne, Catherine Cordonnier & Muhamed-Kheir Taha. (2022) Immunogenicity and safety of the meningococcal B recombinant (4CMenB) vaccine in allogeneic hematopoietic cell transplantation recipients. Clinical Microbiology and Infection 28:12, pages 1609-1614.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.